He Gui, Ji Xuanke, Yan Yali, Wang Kunyan, Song Chunhua, Wang Peng, Ye Hua, Dai Liping, Zhang Jianying, Wang Kaijuan
Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.
Key Laboratory of Tumor Epidemiology of Henan Province, Zhengzhou University, Zhengzhou, China.
Iran J Public Health. 2021 Dec;50(12):2384-2396. doi: 10.18502/ijph.v50i12.7922.
Family history may inform individuals that they are at risk of gastric cancer (GC). However, it is too extensive to conduct intensive screening strategies for all individuals with family history of GC instead of average-risk screening. To establish more precise prevention strategies, accurate risk estimates are necessary for individuals with family history of GC.
We searched PubMed, EMBASE and Cochrane for all relevant studies from their inception to May 21, 2020, for cohort and case-control studies investigating the association between family history of GC and its risk. Relative risk (RR) and 95% confidence interval (CI) were pooled from studies using random-effects or fixed effects.
The RR of GC was 2.08 (95% CI=1.86-2.34) in individuals with family history of GC according to twenty-nine case-control studies and 1.83 (95%CI=1.67-2.01) from six cohort studies. The increased risk was higher in individuals with sibling history of GC than those with parental history of GC (RR=3.18, 95% CI=2.12-4.79 vs. RR=1.66, 95% CI=1.46-1.89, =0.021). For individuals with 2 or more first-degree relatives (FDRs) with GC, the RR was 2.81(95% CI=1.89-3.99). Subjects with both family history and infection confer a higher risk of GC (RR = 4.03, 95%CI=2.46-6.59).
The RR of GC among FDRs is lower than in previous studies. However, the risk of GC is markedly increased in individuals having a sibling with GC, more than 2 FDRs with GC. Intensified screening and eradication therapy for could be considered for these individuals.
家族史可能会告知个体他们有患胃癌(GC)的风险。然而,对所有有胃癌家族史的个体进行强化筛查策略而非平均风险筛查,范围过于广泛。为了制定更精确的预防策略,对有胃癌家族史的个体进行准确的风险评估是必要的。
我们检索了PubMed、EMBASE和Cochrane数据库,从其创建到2020年5月21日的所有相关研究,以查找调查胃癌家族史与其风险之间关联的队列研究和病例对照研究。使用随机效应或固定效应从研究中汇总相对风险(RR)和95%置信区间(CI)。
根据29项病例对照研究,有胃癌家族史的个体患GC的RR为2.08(95%CI = 1.86 - 2.34),6项队列研究的结果为1.83(95%CI = 1.67 - 2.01)。有兄弟姐妹患GC病史的个体的风险增加高于有父母患GC病史的个体(RR = 3.18,95%CI = 2.12 - 4.79对比RR = 1.66,95%CI = 1.46 - 1.89,P = 0.021)。对于有2个或更多患GC的一级亲属(FDR)的个体,RR为2.81(95%CI = 1.89 - 3.99)。有家族史且感染的个体患GC的风险更高(RR = 4.03,95%CI = 2.46 - 6.59)。
FDR中GC的RR低于先前研究。然而,有兄弟姐妹患GC、超过2个FDR患GC的个体患GC的风险显著增加。对于这些个体可考虑加强筛查和根除治疗。